Group of Irish Women Plan Talcum Powder Lawsuits

More than a dozen women in Ireland are looking to file talcum powder ovarian cancer lawsuits against Johnson & Johnson.

Tuesday, December 6, 2016 - A talcum powder attorney representing a group of at least 20 women in Ireland has announced plans to file a number of Johnson & Johnson's baby powder lawsuit early in 2017. The claims will build on worldwide allegations against Johnson & Johnson claiming the company failed to adequately warn consumers about the medically studied ovarian cancer links to its talcum powder products.

The talcum powder lawyer heading the group of claims in Ireland, Bryan Fox, will look to build on the successes that talcum powder lawsuits have had in America during 2016. Three separate Johnson & Johnson's baby powder lawsuits went to trial in the City of St. Louis Circuit Court, all of which were won by the plaintiffs. The juries that heard the cases awarded those plaintiffs nearly $200 million, a staggering number that has caught the attention of the international community.

Johnson & Johnson has continued to fight these claims in large part because of the pervasive nature of their baby powder products. The company is one of the largest healthcare corporations in the world and while baby powder is not one of its biggest money makers, the product's family-friendly nature is a boon for the company's brand and features as one of its more recognizable offerings. The fight to protect talcum powder also is a fight to protect the company's public perception, as a settlement involving baby powder would be a blow to Johnson & Johnson's family-friendly image.

Plaintiffs that have brought talcum powder cancer lawsuits against the company have claimed that part of the reason Johnson & Johnson failed to warn consumers was in the interest of protecting the company's image at the expense of the public's health. Talcum powder lawyers from around the country have claimed that the presence of at least 20 medical studies that have discovered a link between talcum powder and an increased risk for ovarian cancer are enough to establish that Johnson & Johnson knew of the developments regarding the product and in response did not affix warning labels to their baby powders.

The talcum powder lawsuits coming out of Ireland will be announced early in 2017, though the full plans to go along with the litigation will likely progress slowly as the parties involved monitor the status of claims currently pending in the U.S. Despite the three Johnson & Johnson's talcum powder lawsuits won by plaintiffs in 2016, there are still more than 2,000 pending suits against Johnson & Johnson and the company has announced that it plans to continue fighting these claims for the foreseeable future.

Ireland as a country is uniquely sensitive to issues regarding ovarian cancer as it holds the 14th highest ovarian cancer rate in the world, and cracks the top ten for developed countries. The Johnson & Johnson's baby powder lawsuits may point to the company's failure to warn consumers in the country of their product's relation to ovarian cancer as a contributing factor to the disease's high rate in Ireland. Many of the women involved in these claims have already died from the disease, and will be represented by their estates in the potential suits.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.